Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance
Steve Bellan, of the CEID, developed a mathematical model to test the hypothesis that early initiation of antiretroviral therapy (ART) reduces the risk of drug-sensitive HIV transmission but may increase the transmission of drug-resistant HIV. His model estimates the long-term population-level benefits of ART and determines the scenarios under which earlier ART (treatment […]